Answers are grounded in this paper and cite their sources.
Review highlights melatonin's potential in managing mucositis due to chemotherapy in cancer patients, indicating improved quality of life.
The current treatment for cervico-facial cancer involves radio and/or chemotherapy. Unfortunately, cancer therapies can lead to local and systemic complications such as mucositis, which is the most common dose-dependent complication in the oral cavity and gastrointestinal tract. Mucositis can cause a considerably reduced quality of life in cancer patients already suffering from physical and psychological exhaustion. However, the role of melatonin in the treatment of mucositis has recently been investigated, and offers an effective alternative therapy in the prevention and/or management of radio and/or chemotherapy-induced mucositis. This review focuses on the pathobiology and management of mucositis in order to improve the quality of cancer patients' lives.
No takes yet. Share an insight, caveat, or question.
Moneim et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: